Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Downstaging locally advanced hepatocellular carcinoma with selective internal radiation therapy.
Authors
Marjorie Hoang
Duke-NUS Medical School, Singapore, Singapore;
Marjorie Hoang , Pierce K. H. Chow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 536)
DOI
10.1200/JCO.2023.41.4_suppl.536
Abstract #
536
Poster Bd #
C6
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Downstaging radiotherapy and surgical transformation for initially unresectable or borderline resectable hepatocellular carcinoma: A phase II study.
First Author: Ting-Shi Su
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Has management of locally advanced intrahepatic cholangiocarcinoma evolved with the evidence? Trends and practice patterns from the National Cancer Database.
First Author: Lauren E. Schleimer
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Comparison of liver-directed combined radiotherapy versus sorafenib in patients with locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: An Asian Liver Radiotherapy Group Study.
First Author: Jinsil Seong
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Multicenter prospective study to evaluate the efficacy of lenvatinib to achieve conversion surgery for initially unresectable hepatocellular carcinoma: LENS-HCC trial.
First Author: Masaharu Tada